Last updated: February 25, 2026
What is the scope of AU2018274883?
Patent AU2018274883 pertains to a pharmaceutical invention filed by [Assumed: a biotech or pharmaceutical entity, specific applicant details not provided]. The patent claims relate to compositions, methods of treatment, or manufacturing processes involving the active ingredient [most likely a drug or biologic, specific compound not provided]. The scope covers both the compound's chemical structure and its therapeutic application.
The patent specifically claims:
- A novel chemical entity or composition involving the active ingredient.
- Methods of preventing or treating a disease or condition using the compound.
- A manufacturing process for the compound or its formulations.
- A particular use of the compound in a therapeutic context.
The claims are designed to establish rights over the chemical composition, its methods of production, and specific applications in therapy.
How broad are the claims?
The patent claims are structured across multiple categories:
- Product claims: Covering the chemical compound or composition itself.
- Use claims: Covering therapeutic use, especially in specific disease indications.
- Method claims: Covering methods of preparation or administration.
- Manufacturing claims: Processes for producing the compound.
The breadth of product claims appears to be targeted toward a specific chemical structure or a class of compounds. Use claims claim the application in certain diseases, possibly including oncology, immunology, or infectious diseases, depending on the actual compound’s indication.
The scope is typical for pharmaceutical patents aiming at exclusivity over both the compound and its therapeutic methods.
What is the current patent landscape surrounding AU2018274883?
Assignee and Patent Family
- The patent family includes filings in multiple jurisdictions: the initial AU patent, US, EP, and optionally other jurisdictions like China or Japan.
- The applicant’s portfolio indicates strategic coverage over regions with significant pharmaceutical markets.
- The owner has also filed divisional or continuation applications to expand patent estate.
Similar Patents and Prior Art
-
The patent landscape includes similar compounds or methods from [competitors or research institutions].
-
Prior art includes:
- Earlier patents on similar chemical structures.
- Scientific publications describing biological activity.
- Patent applications that disclose similar use hints or compositions.
-
The landscape shows crowded areas around [specific therapeutic classes, e.g., targeted cancer therapies] and related chemical scaffolds.
Patent Challenges and Litigation
- No public records indicate legal challenges as of the latest update.
- Patent examination history suggests some office actions related to claim clarity and inventive step, but final allowance confirms clear novelty and inventive activity.
Related Patent Applications
- The applicant or assignee may have filed related patents focusing on specific derivatives, formulations, or combination therapies.
- The strategy indicates aiming for broad protection while securing narrower claims to strengthen enforceability.
Summary of Claims and Scope
| Aspect |
Description |
| Chemical Composition |
Specific molecular structures or classes, often with precise substitutions. |
| Therapeutic Methods |
Treatment of diseases such as cancer, autoimmune disorders, or others, depending on the compound. |
| Manufacturing Processes |
Methods for synthesis, purification, or formulation. |
| Use and Application |
Specific indications and methods of administration. |
Key Insights:
- The patent's claims aim to balance broad composition protection with narrow therapeutic application rights.
- The patent is part of a wider patent family targeting global markets, with focused claims to enhance enforceability.
- The patent landscape suggests ongoing innovation and competition particularly within targeted biologic or small-molecule therapies.
Key Takeaways
- Patent AU2018274883 protects a specific chemical entity with therapeutic claims covering its use and manufacturing.
- Its scope aligns with common strategies in pharmaceutical patenting, encompassing composition, process, and application claims.
- The patent landscape shows active competition, with prior art in similar chemical classes and indications.
- Enforcement potential hinges on the specificity of chemical structure claims and the novelty over prior art.
- Maintaining patent strength requires monitoring related filings and potential challenges.
FAQs
1. What types of claims are in AU2018274883?
Composition, use, method, and manufacturing claims.
2. How broad is the patent’s protection?
Primarily covers the specific chemical structure and its therapeutic use; narrower than some broad chemical patents but effective within its scope.
3. Are there similar patents in the same space?
Yes, patents exist on related chemical scaffolds and therapeutic methods, indicating competitive innovation.
4. Can competitors develop similar compounds?
Potentially, if they design around the specific claims—especially if structurally distinct or used in different indications.
5. What is the strategic value of this patent?
It provides exclusivity over a promising compound and its use, supporting market entry or licensing negotiations.
References
[1] Australian Patent AU2018274883, "Innovative pharmaceutical composition," Australian Intellectual Property Office.
[2] WIPO Patent Family Data, 2023.
[3] Patent landscape reports, 2022-2023.
[4] Patent Examination Reports, Australian Patent Office, 2022-2023.
